Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for metabolic syndrome with obstructive sleep apnea syndrome
ChiCTR-TRC-14004594Phase 4Completed
- Sponsor
- Pudong Science and Technology Commission
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in cardiometabolic risk (CMR) and obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Pudong Science and Technology Commission. Primary endpoints: Apnea-hypopnea index, Carotid intima-media thickness and 1 more. Started Jan 2014; status: completed.
02
Drugs
metformin
03
Conditions
cardiometabolic risk (CMR)obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR-TRC-14004594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004594.